The Current Ratio as of June 2026 (TTM) for Minerva Neurosciences, Inc. (NERV) is 17.65

According to Minerva Neurosciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 17.65. This represents a change of 8.69% compared to the average of 16.24 of the last 4 quarters.

Minerva Neurosciences, Inc. (NERV) Historical Current Ratio (quarterly & annually)

How has NERV Current Ratio performed in the past?

The mean historical Current Ratio of Minerva Neurosciences, Inc. over the last ten years is 17.63. The current 17.65 Current Ratio has changed 9.91% with respect to the historical average. Over the past ten years (40 quarters), NERV's Current Ratio was at its highest in in the December 2025 quarter at 36.28. The Current Ratio was at its lowest in in the June 2020 quarter at 4.85.

Minerva Neurosciences, Inc. (NERV) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Minerva Neurosciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Minerva Neurosciences, Inc. (NERV) Average Current Ratio

How has NERV Current Ratio performed in the past?

The current Current Ratio of Minerva Neurosciences, Inc. (NERV) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Minerva Neurosciences, Inc. (NERV) Current Ratio vs. Peers

How is NERV’s Current Ratio compared to its peers?

Minerva Neurosciences, Inc.’s Current Ratio is less than Klotho Neurosciences, Inc. (95.01), greater than Sonnet BioTherapeutics Holdings, Inc. (3.50), greater than NeuroSense Therapeutics Ltd. (0.31), greater than Exicure, Inc. (0.79), greater than NeurAxis, Inc. (2.89), greater than CollPlant Biotechnologies Ltd. (2.27), less than TAO Synergies Inc. (27.40), greater than Rallybio Corporation (12.92), greater than Cadrenal Therapeutics, Inc. Common Stock (2.68), less than Enlivex Therapeutics Ltd. (193.24),

Build a custom stock screener for Minerva Neurosciences, Inc. (NERV) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Minerva Neurosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Minerva Neurosciences, Inc. (NERV) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Minerva Neurosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.